Logo for Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Investor Relations Material

Latest events

Logo for Arrowhead Pharmaceuticals Inc

Q2 2024

Arrowhead Pharmaceuticals
Logo for Arrowhead Pharmaceuticals

Q2 2024

9 May, 2024
Logo for Arrowhead Pharmaceuticals

Q1 2024

6 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Arrowhead Pharmaceuticals Inc

Access all reports
Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of intractable diseases in the United States. Its two platform technology includes a subcutaneous gene therapy program, which is focused on developing RNAi candidates targeting RNA sequences that are not amenable to conventional oral delivery through compacted, double-stranded RNA formulations for liver targeted delivery; and peptide platform technology that enables subcutaneous delivery of biologically active oligonucleotide payloads without the need for liposomal or polymeric encapsulation systems.